Viva Ventures Biotech Fund - aVenture Fund Research
Viva Ventures Biotech Fund
Large-scale biotech investment fund, supporting startups from idea to inception.
2016
Viva Ventures Biotech Fund is a large-scale investment firm focusing on biotech startups, supporting companies from the idea stage to inception. The firm typically invests in various stages, including Seed, Series A, and Series C rounds, providing significant financial backing to foster innovation in the biotech sector.
Notable portfolio companies include Anji Pharmaceuticals, Arthrosi Therapeutics, Blue Oak Pharmaceuticals, and SQZ Biotechnologies. Key partners or decision-makers are not specified, but the firm's investment philosophy emphasizes substantial support for early-stage biotech ventures. Viva Ventures Biotech Fund offers unique value-add services tailored to the specific needs of biotech startups, ensuring they have the resources and guidance necessary for successful development and growth.
Viva Ventures Biotech Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies10
Follow-on Investments3
Current Portfolio Count9
Top Investment Stages
Series A7 (53.8%)
Seed3 (23.1%)
Series C3 (23.1%)
Stage Mix
Series A 54%Seed 23%Series C 23%
Concentration shown as share of disclosed investments by stage.
